330 related articles for article (PubMed ID: 16793161)
1. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
[TBL] [Abstract][Full Text] [Related]
2. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines.
Kasturi SP; Sachaphibulkij K; Roy K
Biomaterials; 2005 Nov; 26(32):6375-85. PubMed ID: 15913771
[TBL] [Abstract][Full Text] [Related]
3. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
Biragyn A; Tani K; Grimm MC; Weeks S; Kwak LW
Nat Biotechnol; 1999 Mar; 17(3):253-8. PubMed ID: 10096292
[TBL] [Abstract][Full Text] [Related]
4. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
5. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.
Rinaldi M; Fioretti D; Iurescia S; Signori E; Pierimarchi P; Seripa D; Tonon G; Fazio VM
Biochem Biophys Res Commun; 2008 May; 370(2):279-84. PubMed ID: 18364239
[TBL] [Abstract][Full Text] [Related]
7. Microparticle-mediated gene delivery for the enhanced expression of a 19-kDa fragment of merozoite surface protein 1 of Plasmodium falciparum.
Liu S; Danquah MK; Forde GM; Ma C; Wang L; Coppel R
Biotechnol Prog; 2010; 26(1):257-62. PubMed ID: 19924768
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
Fredriksen AB; Sandlie I; Bogen B
Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
[TBL] [Abstract][Full Text] [Related]
10. [Construction of a DNA vaccine against human B cell lymphoma].
Zhang YS; Zhong KL; Yuan Y; Zhang MW; Zhang Y; Mao N
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):79-82. PubMed ID: 15182628
[TBL] [Abstract][Full Text] [Related]
11. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
Fischer S; Uetz-von Allmen E; Waeckerle-Men Y; Groettrup M; Merkle HP; Gander B
Biomaterials; 2007 Feb; 28(6):994-1004. PubMed ID: 17118442
[TBL] [Abstract][Full Text] [Related]
12. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.
Spellerberg MB; Zhu D; Thompsett A; King CA; Hamblin TJ; Stevenson FK
J Immunol; 1997 Aug; 159(4):1885-92. PubMed ID: 9257853
[TBL] [Abstract][Full Text] [Related]
14. [The experimental study on idiotypic DNA vaccine against human B-cell lymphoma to induce antitumor immune response].
Zhong KL; Zhang WJ; Yuan Y; Wu Y; Zhang MW; Mao N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):609-15. PubMed ID: 14706145
[TBL] [Abstract][Full Text] [Related]
15. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
Thomas C; Gupta V; Ahsan F
Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
Kazzaz J; Singh M; Ugozzoli M; Chesko J; Soenawan E; O'Hagan DT
J Control Release; 2006 Feb; 110(3):566-73. PubMed ID: 16360956
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
[TBL] [Abstract][Full Text] [Related]
18. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
19. Development of new polymer-based particulate systems for anti-glioma vaccination.
Sapin A; Garcion E; Clavreul A; Lagarce F; Benoit JP; Menei P
Int J Pharm; 2006 Feb; 309(1-2):1-5. PubMed ID: 16386390
[TBL] [Abstract][Full Text] [Related]
20. Microparticles for the delivery of DNA vaccines.
O'Hagan DT; Singh M; Ulmer JB
Immunol Rev; 2004 Jun; 199():191-200. PubMed ID: 15233735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
